Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

INSULIN DETEMIR for Latent autoimmune diabetes in adults: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 18 adverse event reports in the FDA FAERS database where INSULIN DETEMIR was used for Latent autoimmune diabetes in adults.

Most Reported Side Effects for INSULIN DETEMIR

Side Effect Reports % Deaths Hosp.
Blood glucose increased 1,975 20.5% 7 468
Blood glucose decreased 603 6.3% 10 164
Hypoglycaemia 418 4.3% 21 284
Foetal exposure during pregnancy 367 3.8% 17 195
Glycosylated haemoglobin increased 301 3.1% 3 66
Drug ineffective 298 3.1% 0 65
Cerebrovascular accident 294 3.1% 27 140
Dizziness 290 3.0% 0 41
Malaise 288 3.0% 5 35
Visual impairment 275 2.9% 1 32
Diabetes mellitus inadequate control 257 2.7% 5 74
Fall 236 2.5% 5 107
Diabetic ketoacidosis 219 2.3% 3 193
Arthritis 213 2.2% 1 13
Weight decreased 205 2.1% 3 47

Other Indications for INSULIN DETEMIR

Product used for unknown indication (3,636) Type 2 diabetes mellitus (3,260) Diabetes mellitus (1,116) Type 1 diabetes mellitus (794) Gestational diabetes (280) Diabetes mellitus inadequate control (36) Insulin-requiring type 2 diabetes mellitus (28) Foetal exposure during pregnancy (13) Hyperglycaemia (11) Hypertension (11)

Other Drugs Used for Latent autoimmune diabetes in adults

INSULIN LISPRO (119) INSULIN GLARGINE (110) EMPAGLIFLOZIN (50) INSULIN ASPART (48) INSULIN DEGLUDEC (37) INSULIN HUMAN (33) DULAGLUTIDE (24) CANAGLIFLOZIN (21) DAPAGLIFLOZIN (18) METFORMIN (16)

Related Pages

INSULIN DETEMIR Full Profile All Latent autoimmune diabetes in adults Drugs INSULIN DETEMIR Demographics INSULIN DETEMIR Timeline